4//SEC Filing
Shendelman Shoshana 4
Accession 0001209191-23-003290
CIK 0001697532other
Filed
Jan 12, 7:00 PM ET
Accepted
Jan 13, 4:34 PM ET
Size
12.0 KB
Accession
0001209191-23-003290
Insider Transaction Report
Form 4
Shendelman Shoshana
DirectorPresident and CEO10% Owner
Transactions
- Sale
Common Stock
2023-01-11$0.91/sh−15,870$14,442→ 751,625 total - Award
Common Stock
2023-01-11+1,964,362→ 2,715,987 total
Holdings
- 1,750,000(indirect: See footnote)
Common Stock
- 290,280(indirect: See footnote)
Common Stock
- 1,492,094(indirect: See footnote)
Common Stock
- 709,720(indirect: See footnote)
Common Stock
- 88,397(indirect: See footnote)
Common Stock
Footnotes (8)
- [F1]The sale reported on this Form 4 represents shares sold by the reporting person to cover tax withholding obligations in connection with the vesting and settlement of compensatory Restricted Stock Units. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the reporting person.
- [F2]Includes 1,725,000 compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. Each compensatory Restricted Stock Unit represents a contingent right to receive one share of the issuer's common stock. One-fourth (1/4th) of the compensatory Restricted Stock Units shall vest on January 11, 2024, and one thirty-sixth (1/36th) of the remaining shares subject to the compensatory Restricted Stock Units shall vest each month thereafter, subject to the reporting person continuing to provide services through each such date.
- [F3]Includes 239,362 compensatory Restricted Stock Units granted under Applied Therapeutics, Inc.'s 2019 Equity Incentive Plan. The issuer determined to make this compensatory grant of Restricted Stock Units to the reporting person in lieu of a cash bonus that otherwise would have been paid with respect to 2022. All of the shares subject to the compensatory Restricted Stock Units vested immediately upon grant.
- [F4]Through a grantor retained annuity trust.
- [F5]Through a family trust controlled by the reporting person's spouse.
- [F6]Through the reporting person's spouse.
- [F7]Through a family trust controlled by the reporting person.
- [F8]Through Clearpoint Strategy Group LLC of which the reporting person is the sole owner.
Documents
Issuer
Applied Therapeutics Inc.
CIK 0001697532
Entity typeother
Related Parties
1- filerCIK 0001775490
Filing Metadata
- Form type
- 4
- Filed
- Jan 12, 7:00 PM ET
- Accepted
- Jan 13, 4:34 PM ET
- Size
- 12.0 KB